蒽环类-话题@MedSci

#蒽环类#

35篇内容 | 2237人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1521695, encodeId=204f152169517, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=Int J Cardiol：蒽环类和曲妥珠单抗治疗乳腺癌后心脏效应的晚期特征！, objectType=article, longId=131954, objectId=44c9131954e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44c9131954e8, replyNumber=0, likeNumber=76, createdTime=2018-03-11, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44c9131954e8, moduleTitle=Int J Cardiol：蒽环类和曲妥珠单抗治疗乳腺癌后心脏效应的晚期特征！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44c9131954e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521694, encodeId=e1491521694af, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=中国蒽环类药物治疗乳腺癌专家共识要点前瞻, objectType=article, longId=123278, objectId=981e1232e8d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981e1232e8d3, replyNumber=0, likeNumber=75, createdTime=2017-12-15, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981e1232e8d3, moduleTitle=中国蒽环类药物治疗乳腺癌专家共识要点前瞻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981e1232e8d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521693, encodeId=ac371521693ab, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=JAHA：乳腺癌患者蒽环类药物治疗期间神经激素阻断和循环心血管生物标志物变化！, objectType=article, longId=119416, objectId=c761119416dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c761119416dc, replyNumber=0, likeNumber=151, createdTime=2017-11-11, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c761119416dc, moduleTitle=JAHA：乳腺癌患者蒽环类药物治疗期间神经激素阻断和循环心血管生物标志物变化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c761119416dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521692, encodeId=a6851521692b4, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=《中国蒽环类化疗药物临床应用专家共识》即将发布，胡夕春、王树森、王晓稼和张剑解读共识主要内容, objectType=article, longId=119407, objectId=1f5211940e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f5211940e81, replyNumber=0, likeNumber=67, createdTime=2017-11-11, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f5211940e81, moduleTitle=《中国蒽环类化疗药物临床应用专家共识》即将发布，胡夕春、王树森、王晓稼和张剑解读共识主要内容, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f5211940e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521691, encodeId=658f152169182, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=2017 临床实践指南：儿童肿瘤患者输注蒽环类药物需持续1小时, objectType=article, longId=118854, objectId=c6f411885436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6f411885436, replyNumber=0, likeNumber=42, createdTime=2017-11-07, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6f411885436, moduleTitle=2017 临床实践指南：儿童肿瘤患者输注蒽环类药物需持续1小时, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6f411885436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521690, encodeId=58d815216906a, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=JCO:三氧化二砷可减低蒽环类药物在儿童APL中的用量，且不影响疗效？, objectType=article, longId=111007, objectId=c32f11100eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c32f11100eea, replyNumber=0, likeNumber=64, createdTime=2017-08-28, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c32f11100eea, moduleTitle=JCO:三氧化二砷可减低蒽环类药物在儿童APL中的用量，且不影响疗效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c32f11100eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521689, encodeId=8b6d1521689ab, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=JCO：“砒霜”可减少急性早幼粒细胞白血病中蒽环类药物剂量, objectType=article, longId=107615, objectId=983210e615c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=983210e615c3, replyNumber=0, likeNumber=60, createdTime=2017-08-05, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=983210e615c3, moduleTitle=JCO：“砒霜”可减少急性早幼粒细胞白血病中蒽环类药物剂量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=983210e615c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521688, encodeId=f5ad15216881e, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=Blood：使用含蒽环类药物化疗结合化疗增加霍奇金淋巴瘤生存者罹患心脏衰竭概率3倍, objectType=article, longId=97109, objectId=d4f09e109ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4f09e109ad, replyNumber=0, likeNumber=85, createdTime=2017-04-27, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4f09e109ad, moduleTitle=Blood：使用含蒽环类药物化疗结合化疗增加霍奇金淋巴瘤生存者罹患心脏衰竭概率3倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4f09e109ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521687, encodeId=7076152168e38, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=JAHA：接受蒽环类化疗的儿童和年轻成人心脏毒性的潜在标志物, objectType=article, longId=94739, objectId=cdfc94e3954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdfc94e3954, replyNumber=0, likeNumber=113, createdTime=2017-04-07, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdfc94e3954, moduleTitle=JAHA：接受蒽环类化疗的儿童和年轻成人心脏毒性的潜在标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdfc94e3954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521686, encodeId=67cf152168621, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=The Oncologist：蒽环类药物诱导心脏毒性的现代治疗, objectType=article, longId=92006, objectId=71bd920061c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71bd920061c, replyNumber=0, likeNumber=67, createdTime=2017-03-17, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71bd920061c, moduleTitle=The Oncologist：蒽环类药物诱导心脏毒性的现代治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71bd920061c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521685, encodeId=8c251521685b2, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=Circulation：蒽环类药物引起的心脏毒性早期检测及心脏衰竭的早期改善, objectType=article, longId=51783, objectId=afab51e831d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afab51e831d, replyNumber=0, likeNumber=75, createdTime=2015-06-09, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afab51e831d, moduleTitle=Circulation：蒽环类药物引起的心脏毒性早期检测及心脏衰竭的早期改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afab51e831d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521684, encodeId=a4881521684eb, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=JNCI:蒽环类与曲妥珠单抗带来心脏衰竭风险, objectType=article, longId=9508, objectId=5d52950839, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d52950839, replyNumber=0, likeNumber=68, createdTime=2012-09-06, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d52950839, moduleTitle=JNCI:蒽环类与曲妥珠单抗带来心脏衰竭风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d52950839)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521683, encodeId=ac3d1521683ce, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=FOXP3 与乳腺癌蒽环类疗效, objectType=article, longId=5022, objectId=4134502258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4134502258, replyNumber=0, likeNumber=70, createdTime=2012-04-13, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4134502258, moduleTitle=FOXP3 与乳腺癌蒽环类疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4134502258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521682, encodeId=3cf71521682c8, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=Ann Onco：FOXP3表达示蒽环类抗乳腺癌效果, objectType=article, longId=4439, objectId=531b4439fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=531b4439fe, replyNumber=0, likeNumber=75, createdTime=2012-04-01, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=531b4439fe, moduleTitle=Ann Onco：FOXP3表达示蒽环类抗乳腺癌效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=531b4439fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521681, encodeId=086b1521681da, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=蒽环类药物心脏毒性防治共识, objectType=article, longId=3294, objectId=7e3f329449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e3f329449, replyNumber=0, likeNumber=75, createdTime=2011-11-14, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e3f329449, moduleTitle=蒽环类药物心脏毒性防治共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e3f329449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1521680, encodeId=56081521680ca, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, objectTitle=蒽环类药物心脏毒性保护剂临床应用的热点问题, objectType=article, longId=3293, objectId=2d6c32932b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d6c32932b, replyNumber=0, likeNumber=55, createdTime=2011-11-14, rootId=0, userName=shijzhiewnjhch, userId=97d111387900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d6c32932b, moduleTitle=蒽环类药物心脏毒性保护剂临床应用的热点问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d6c32932b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

蒽环类

2020-05-29

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

Int J Cardiol：蒽环类和曲妥珠单抗治疗乳腺癌后心脏效应的晚期特征！

2018-03-11

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

中国蒽环类药物治疗乳腺癌专家共识要点前瞻

2017-12-15

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

JAHA：乳腺癌患者蒽环类药物治疗期间神经激素阻断和循环心血管生物标志物变化！

2017-11-11

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

《中国蒽环类化疗药物临床应用专家共识》即将发布，胡夕春、王树森、王晓稼和张剑解读共识主要内容

2017-11-11

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

2017 临床实践指南：儿童肿瘤患者输注蒽环类药物需持续1小时

2017-11-07

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

JCO:三氧化二砷可减低蒽环类药物在儿童APL中的用量，且不影响疗效？

2017-08-28

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

JCO：“砒霜”可减少急性早幼粒细胞白血病中蒽环类药物剂量

2017-08-05

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

Blood：使用含蒽环类药物化疗结合化疗增加霍奇金淋巴瘤生存者罹患心脏衰竭概率3倍

2017-04-27

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

JAHA：接受蒽环类化疗的儿童和年轻成人心脏毒性的潜在标志物

2017-04-07

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

The Oncologist：蒽环类药物诱导心脏毒性的现代治疗

2017-03-17

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

Circulation：蒽环类药物引起的心脏毒性早期检测及心脏衰竭的早期改善

2015-06-09

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

JNCI:蒽环类与曲妥珠单抗带来心脏衰竭风险

2012-09-06

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

FOXP3 与乳腺癌蒽环类疗效

2012-04-13

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

Ann Onco：FOXP3表达示蒽环类抗乳腺癌效果

2012-04-01

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

蒽环类药物心脏毒性防治共识

2011-11-14

shijzhiewnjhch (审核中...)

前往app查看评论内容

#蒽环类#

蒽环类药物心脏毒性保护剂临床应用的热点问题

2011-11-14

科室
- - 订阅+
  - 更多科室
工具
服务